Hepatocellular carcinoma (HCC) is a major global health issue, with significant morbidity and mortality rates. As the sixth most common cancer and the third leading cause of cancer-related deaths, HCC ...

As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...

INSITE Trial included more than 400 patients at 14 leading academic and community cancer centers Intracavity visualization system uses fluorescence imaging designed to identify residual cancer and ...

A research group from Nagoya University has successfully developed a surgical training model using konjac, a processed jelly made from the bulb of the konjac plant. Konjac is commonly used as an ...

Successful surgery for head and neck squamous cell carcinoma (HNSCC) relies upon complete tumor removal and safe preservation of the fragile nerves in the vicinity. Both are challenging. Fluorescence ...

Light-guided cancer surgery has been in development for some time with varying degrees of success, from light therapy to glow-in-the-dark tumors and the development of compounds that can illuminate ...

A Bohemia-based firm is introducing its wearable specialty lighting for brain surgeons. The system aims help enable doctors to quickly operate during brain tumor surgery. Designs for Vision recently ...

The nerve-illuminating agent rizedisben achieved sustained fluorescence during laparoscopic prostatectomy All nine patients receiving a dose of 3 mg/kg showed obturator nerve fluorescence, as well as ...

In a significant leap forward for successful cancer surgery, researchers at the University of Missouri and collaborators have developed a new imaging probe to help surgeons more accurately identify ...

MADISON, Wis.--(BUSINESS WIRE)--OnLume Surgical, a Wisconsin-based medical device company developing novel imaging systems for use during surgery, announced the completion of its Series A funding to ...